Last reviewed 2026-05-22 · How we verify

Temaril (alimemazine)

FDA-approved active Under review Quality 23/100

Temaril (generic name: alimemazine) is a trimeprazine drug. It is currently FDA-approved for Allergic conjunctivitis, Allergic rhinitis, Angioedema.

Temaril, also known as Alimemazine or Trimeprazine, is a small molecule with antipruritic, sedative, hypnotic, and antiemetic properties. It has been studied in clinical trials for various conditions, including active cocaine users, ADHD, and Autism Spectrum Disorder, and has been compared to other stimulant medications such as amphetamine and methylphenidate.

At a glance

Generic name	alimemazine
Drug class	trimeprazine
Target	Histamine H1 receptor
Therapeutic area	Dermatology
Phase	FDA-approved

Approved indications

Allergic conjunctivitis
Allergic rhinitis
Angioedema
Dermatographic urticaria
General anesthesia
Itching of skin
Nasal congestion
Nasal discharge
Sneezing
Urticaria

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Temaril CI brief — competitive landscape report
Temaril updates RSS · CI watch RSS
portfolio CI

Frequently asked questions about Temaril

What is Temaril?

Temaril (alimemazine) is a trimeprazine drug, indicated for Allergic conjunctivitis, Allergic rhinitis, Angioedema.

What is Temaril used for?

Temaril is indicated for Allergic conjunctivitis, Allergic rhinitis, Angioedema, Dermatographic urticaria, General anesthesia.

What is the generic name of Temaril?

alimemazine is the generic (nonproprietary) name of Temaril.

What drug class is Temaril in?

Temaril belongs to the trimeprazine class. See all trimeprazine drugs at /class/trimeprazine.

What development phase is Temaril in?

Temaril is FDA-approved (marketed).

What does Temaril target?

Temaril targets Histamine H1 receptor and is a trimeprazine.

Drug class: All trimeprazine drugs
Target: All drugs targeting Histamine H1 receptor
Manufacturer: — full pipeline
Therapeutic area: All drugs in Dermatology
Indication: Drugs for Allergic conjunctivitis
Indication: Drugs for Allergic rhinitis
Indication: Drugs for Angioedema

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing